Continued Gap in Seizure Frequency Documentation

Abstract

Proper documentation during neurology clinic visits is essential. Medical providers that document precise and standardized findings aid other providers, nurses, and research personnel. The American Academy of Neurology (AAN) created standardized quality measures in order to improve delivery of care for patients with epilepsy, providers, and systems. In this article, we reviewed a total of 777 charts in order to find documentation on seizure frequency from the most recent clinical visit. Data was collected from electronic healthcare records. During initial chart review, the following information was noted: age, gender, seizure type(s), etiology type(s), provider (neurologist or epileptologist), whether seizure frequency was noted, and the reason for no documentation. The data review represented a sample of the epilepsy population seen at our institution. Of the 734 individuals, 475 patients had seizure frequency documented (65%). Two hundred and fifty-nine (259) people (35%) were missing seizure frequency data. For those individuals, we determined the reasoning behind why this data was not present in the chart note. Of those 259 charts, there were 65 (25%) charts missing seizure frequency, 161 (62%) charts that were vague, and 33 (13%) charts where seizure frequency could not be determined. Based on our findings, the documentation of seizure frequency is a gap in care.

Keywords

epilepsy - seizure - frequency - quality - measure

Data Availability Statement

Anonymized data will be shared by request from any qualified investigator.

Publication History

Received: 28 April 2020

Accepted: 06 July 2020

Article published online:
31 August 2020

• References

• 1 Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever Jr. CT. American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association-Convened Physician Consortium for Performance Improvement Independent Measure Development Process. Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology 2011; 76 (01) 94-99
• 2 Patel AD, Baca C, Franklin G. et al. Quality improvement in neurology: Epilepsy Quality Measurement Set 2017 update. Neurology 2018; 91 (18) 829-836
• 3 Fountain NB. Delivering quality care in epilepsy. Curr Opin Neurol 2013; 26 (02) 174-178
• 4 Hoppe C, Poepel A, Elger CE. Epilepsy: accuracy of patient seizure counts. Arch Neurol 2007; 64 (11) 1595-1599
• 5 Carvill GL, Dulla CG, Lowenstein DH, Brooks-Kayal AR. The path from scientific discovery to cures for epilepsy. Neuropharmacology 2020; 167: 107702
• 6 Gattone P, Lammert W. Epilepsy Foundation's "#DareTo" campaign. Epilepsy Behav 2015; 42: 1
• 7 Gedela S, Freedman DA, Gedela S, Glynn P, Salvator A, Patel AD. Safety and efficacy of supratherapeutic doses of clobazam. J Child Neurol 2019; 34 (12) 735-738
• 8 Fisher RS. The new classification of seizures by the International League Against Epilepsy 2017. Curr Neurol Neurosci Rep 2017; 17 (06) 48
• 9 Aghaei-Lasboo A, Fisher RS. Methods for measuring seizure frequency and severity. Neurol Clin 2016; 34 (02) 383-394 , viii
• 10 Ferastraoaru V, Goldenholz DM, Chiang S, Moss R, Theodore WH, Haut SR. Characteristics of large patient-reported outcomes: where can one million seizures get us?. Epilepsia Open 2018; 3 (03) 364-373
• 11 Goldenholz DM, Goldenholz SR, Moss R. et al. Is seizure frequency variance a predictable quantity?. Ann Clin Transl Neurol 2018; 5 (02) 201-207
• 12 Budrionis A, Bellika JG. The learning healthcare system: where are we now? A systematic review. J Biomed Inform 2016; 64: 87-92